Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

S Lonardi, A Sobrero, G. Rosati, M Di Bartolomeo, M Ronzoni, G. Aprile, B Massida, Mario Scartozzi, M Banzi, M G Zampino, F. Pasini, P Marchetti, M. Cantore, A Zaniboni, L Rimassa, L Ciuffreda, D. Ferrari, S. Barni, V Zagonel, E MaielloE Rulli, R. Labianca, TOSCA (Three or Six Colon Adjuvant) Investigators

Research output: Contribution to journalArticle

Original languageEnglish
JournalAnnals of Oncology
DOIs
Publication statusE-pub ahead of print - Feb 23 2017

Keywords

  • Journal Article

Cite this

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Massida, B., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., ... TOSCA (Three or Six Colon Adjuvant) Investigators (2017). Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. Annals of Oncology. https://doi.org/10.1093/annonc/mdx021